Procter & Gamble (PG.US) Price Target 2026/2027: 10% Upside + 3.0% Dividend

148.41
Price history for Procter & Gamble (PG.US) – stock price at $148.41, October 2026
Procter & Gamble stock price – price development 2026. Updated Oct 7, 2026.
Share this analysis:

Procter & Gamble Price Target 2026: Analysts See 8% Upside

The average price target for Procter & Gamble is $160.61. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 8.22% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.

Is Procter & Gamble overvalued or undervalued?

Procter & Gamble is currently fairly valued with a gap of 8.2% relative to the price target.


The current price is $148.41, which places Procter & Gamble in the fairly valued category. The stock is considered undervalued when the price is below $144.55, and overvalued when the price exceeds $176.67.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For Procter & Gamble, the fair value range lies between $144.55 and $176.67.


See the full price target analysis for Procter & Gamble →

Analyst Ratings for Procter & Gamble stock in 2026: Buy

25 analysts cover Procter & Gamble. The ratings are mixed, with 52% Buy, 48% Hold and 0% Sell. The average price target is $160.61, which gives an upside of 8.2% from the current price.

Consensus: Buy (3.80/5)
Strong Buy
7 (28%)
Buy
6 (24%)
Hold
12 (48%)
Strong Sell Sell Hold Buy Strong Buy
3.80 out of 5 based on 25 analysts

About Procter & Gamble – Household & Personal Products

Procter & Gamble, also known as P&G, makes and sells many well-known everyday products. The company earns money by selling these products to consumers around the world.

P&G's business is split into five main areas. These include Beauty, with brands like Head & Shoulders and Olay, and Personal Care, with brands like Gillette. The company also has areas focused on Baby Care, Feminine Care, and Family Care.

P&G sells its products almost everywhere in the world, including Europe, Asia, and the United States. Its customers are everyday consumers who buy household and personal care products.

The company was founded in 1837. It has been making and selling household products for a very long time, and it continues to do so for millions of people today.
Read more about the company

Key Figures for Procter & Gamble

$337B Market cap
$87.0B Revenue
Household & Personal Products Industry
21.89 P/E
3.87 P/S
6.46 P/B
United States Listed on exchange

What kind of stock is Procter & Gamble?

Dividend stock Quality stock

Procter & Gamble is classified as a dividend stock and quality stock. This means the stock combines several attractive traits, including a dividend of 3.0%, strong financial health (Piotroski 7/9).

Score Overview for Procter & Gamble

💰 Value Score 45/100 (Neutral)
⭐ Quality Score 78/100 (High)
🚀 Momentum Score 67/100 (High)
📊 Total Score 63/100

📈 Valuation

Procter & Gamble trades at a P/E ratio of 21.9, which is close to the market average. The forward P/E is 21.2 (3% lower), which suggests the market expects rising earnings. The P/S ratio is 3.9. The P/B ratio is 6.5. The PEG ratio is 3.79 — above 2.0 suggests the stock is expensive relative to its growth rate.

💵 Profitability & Growth

Procter & Gamble has a profit margin of 18.4% (solid) and an operating margin of 22.1%. Return on equity (ROE) is 30.3% — excellent return on equity. Return on assets (ROA) is 10.7%. The latest quarterly earnings grew -15.5% year over year — falling earnings.

🏦 Financial Health

The Piotroski score is 7 out of 9 — good financial health. Altman Z2 is 4.77 (healthy balance sheet — low risk). The debt-to-equity ratio (D/E) is 140.3% — moderate debt.

🚀 Momentum & Short Interest

Short interest is 1.04% — low, the market does not expect a decline.

Procter & Gamble Dividend 2026: 3.0% Dividend Yield

Dividend Key Figures for Procter & Gamble

Dividend yield
2.96%
Latest dividend per share
1.09 USD
Payout ratio
62.3%
High
Dividend growth (6 years)
+3.8%
Avg. annual dividend (3 years)
3.46 USD

When does Procter & Gamble pay a dividend in 2026?

Latest ex-dividend date (traded without the dividend)
July 24, 2026
Latest payment date
August 17, 2026

How much does Procter & Gamble pay in dividends?

Procter & Gamble pays dividends to its shareholders. The most recently paid dividend was 1.09 USD per share, which corresponds to a dividend yield of 2.96%. Over the last 6 years, the annual dividend has grown by 3.8%, which shows positive dividend growth.

The payout ratio is 62.3%, which is relatively high. The company pays out a large share of its profits as dividends, but there is still a buffer.

Historical Dividend Payments for Procter & Gamble

We have registered dividend payments for Procter & Gamble since Jan 23, 2020. In that period the stock has paid a dividend 26 times, most recently on Jul 24, 2026. This stock qualifies as a stable dividend stock, because it has paid a dividend at least once a year for the last 5 years. That makes it attractive to investors looking for steady, regular dividend payments.

Ex-datePayment dateAmountCurrency
2026-07-242026-08-171.09USD
2026-04-242026-05-151.09USD
2026-01-232026-02-171.06USD
2025-10-242025-11-171.06USD
2025-07-182025-08-151.06USD
2025-04-212025-05-151.06USD
2024-10-182024-11-151.01USD
2024-07-192024-08-151.01USD
2024-04-182024-05-151.01USD
2024-01-182024-02-150.94USD
2023-10-192023-11-150.94USD
2023-07-202023-08-150.94USD
2023-04-202023-05-150.94USD
2023-01-192023-02-150.91USD
2022-10-202022-11-150.91USD
2022-07-212022-08-150.91USD
2022-04-212022-05-160.91USD
2022-01-202022-02-150.87USD
2021-10-212021-11-150.87USD
2021-07-222021-08-160.87USD
2021-04-222021-05-170.87USD
2021-01-212021-02-160.79USD
2020-10-222020-11-160.79USD
2020-07-232020-08-170.79USD
2020-04-232020-05-150.79USD
2020-01-232020-02-180.75USD

Insider Trading in Procter & Gamble 2026: The Signal Is negative

In 2026, insiders at Procter & Gamble have made 20 transactions, all of which were sales. On a net basis, insiders took $10,102,880 out of the stock. Active insiders include Whaley Susan Street, Schulten Andre, Gama Paul and others. In the short term (last 3 months), the insider signal is negative.

Short-Term Signal (3 months): Negative

Insiders have exclusively sold shares over the last 3 months.

Over the last 3 months: 0 purchases and 17 sales. A net $8,029,458 out of the stock.

Long-Term Signal (all transactions): Negative

Insiders have exclusively sold shares in the recent period. This can suggest management sees limited opportunity.

Across the last 20 transactions: 0 purchases and 20 sales. A net $10,102,880 out of the stock.

Latest sale: Whaley Susan Street sold 2,369 shares at $145.34 each on 2026-10-05.

Who is selling: Whaley Susan Street, Schulten Andre, Gama Paul, Janzaruk Matthew W., Raman Sundar G. and others.

Latest Insider Trades in Procter & Gamble (2026)

The table shows the last 20 reported insider transactions in Procter & Gamble. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share ($) Total amount ($)
2026-10-05 Whaley Susan Street Sell 2,369 145 344,310
2026-10-05 Schulten Andre Sell 3,914 145 568,861
2026-10-05 Gama Paul Sell 2,225 145 323,382
2026-08-24 Janzaruk Matthew W. Sell 359 145 52,141
2026-08-21 Raman Sundar G. Sell 3,435 143 491,274
2026-08-20 Whaley Susan Street Sell 2,238 144 321,802
2026-08-20 Schulten Andre Sell 5,402 144 776,754
2026-08-20 Santos de Azevedo Juliana Monteiro Sell 2,368 144 340,495
2026-08-20 Purushothaman Balaji Sell 2,019 144 290,312
2026-08-20 Pritchard Marc S. Sell 4,030 144 579,474

Who is buying and selling Procter & Gamble shares in 2026?

The following insiders have sold shares: Whaley Susan Street, Schulten Andre, Gama Paul, Janzaruk Matthew W., Raman Sundar G. and others. In total, $10,102,880 was sold across 20 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

Procter & Gamble Short Selling 2026: 1.0% Sold Short

Low short interest: 1.0% of the free float
Short % of free float
1.0%
Assessment
Low short interest
Short squeeze risk
Low
Data source
EODHD
Reported about twice a month

Short interest over time: Procter & Gamble

0.0%0.7%1.5%
5/307/299/28
1.0% today (low)Essentially unchanged over the last 30 daysMeasured over 121 days
What does the trend tell you?
Short interest in Procter & Gamble has been fairly stable at 1.0% over the period. Neither many new short sellers have arrived nor many positions been closed.

What matters is when the curve starts to move. This is how shorting works: whoever shorts has borrowed the share and sold it, and to close the position again they must buy the share back. When short interest falls, shares are being bought back. So it is worth watching the trend, not just today's number.
The stock has a low share of short selling. Less than 2% of the freely traded shares are sold short, which points to limited bearish sentiment.

Short interest comes from our data provider EODHD. The figure is reported about twice a month; we check it every trading day.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
▲
1.0%

When Does Procter & Gamble Report Earnings – Next Date: Oct 22, 2026

The next earnings report from Procter & Gamble is scheduled for October 22, 2026, before the market opens. This report covers the third quarter (Q3), which ended on September 30, 2026.



Technical Analysis of Procter & Gamble 2026 – Signal: Buy

Overall Technical Signal: Buy

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated October 7, 2026.

Technical analysis of Procter & Gamble (PG.US) – RSI 56, MACD positive (bullish), daily candlestick chart October 2026
Procter & Gamble technical analysis – candlestick chart with RSI, MACD and volume profile. Updated Oct 7, 2026.

Trend Analysis of The Procter & Gamble Company

The Procter & Gamble Company is in a short-term uptrend. The price of $148.41 is 1.5% above the 20-day average ($146.20). Medium term, the picture is positive: the price is 1.9% above the 50-day average ($145.70). Long term, the stock is 1.5% above the 200-day average ($146.25), which confirms a long-term uptrend.

Death Cross: The 50-day average (145.70) is below the 200-day average (146.25), which is a classic bearish signal for The Procter & Gamble Company.

Is The Procter & Gamble Company overbought or oversold?

The Procter & Gamble Company has an RSI of 56.3. The stock shows positive momentum in the upper part of the neutral zone. Combined with the positive trend, this supports the bullish picture.

MACD Analysis for The Procter & Gamble Company

Daily MACD: MACD is positive (0.216), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is below the signal line (0.228) by 0.012, which suggests the positive momentum is fading – the trend could be turning.

Weekly MACD: MACD5 is negative (-0.104), which indicates a broader bearish long-term trend. MACD5 is above the signal line (-0.259) by 0.155, which suggests the negative long-term momentum is fading – a bigger trend reversal could be ahead.

Overall MACD assessment: The daily and weekly MACD give conflicting signals. The short-term trend is bullish, but the long-term trend is still bearish. Weekly momentum is rising, though, which could signal an upcoming trend reversal.

Risk Profile for The Procter & Gamble Company

The Procter & Gamble Company has an annual standard deviation of 19.9%, which classifies the stock as Conservative. Price swings are limited, and the stock suits conservative investors.

Overall Technical Conclusion for The Procter & Gamble Company

Trend: Positive. The price trades above SMA50 and SMA200.

MACD trend (zero line): Daily bullish (0.216). Weekly bearish (-0.104).

MACD momentum (signal): Daily falling. Weekly rising.

RSI: 56.3 – neutral.

Technical signal: Buy

The broader trend is positive and MACD supports the picture. Consider buying with a stop-loss below the nearest support level.

Frequently Asked Questions About Procter & Gamble stock in 2026

Should you buy Procter & Gamble stock now?
Yes, the technical signal for Procter & Gamble is currently Buy. Procter & Gamble trades at $148.41 as of Oct 7, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 0.216 with falling momentum (signal: 0.228); RSI is at 56.3 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $160.61 points to 8.2% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Procter & Gamble stock?
The average analyst price target for Procter & Gamble is $160.61. The current price is $148.41, which gives an upside of 8.2%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $144.55 and $176.67.
Is Procter & Gamble a dividend stock?
Yes, Procter & Gamble is a dividend stock with a dividend yield of 2.96%. The latest dividend was $1.09 per share. The latest ex-dividend date (traded without the dividend) was Jul 24, 2026. The payout ratio is 62.3%, which is considered moderate.
When does Procter & Gamble pay a dividend in 2026?
The next dividend date for Procter & Gamble has not been set yet. The latest ex-dividend date (last trading day with dividend rights) was Jul 24, 2026. The latest dividend was $1.09 per share with an ex-dividend date of Jul 24, 2026. The dividend yield is 2.96%. The payout ratio of 62.3% points to moderate dividend coverage.
What is the risk of Procter & Gamble stock?
Procter & Gamble is rated as a stock in the risk category Conservative. the annual standard deviation is 19.9%, which classifies the stock as Conservative.
Is Procter & Gamble overvalued?
Procter & Gamble is considered fairly valued – the price is close to the analyst price target. Procter & Gamble has the following valuation ratios: a P/E ratio of 21.9 (moderately to highly valued), a P/S ratio of 3.9, a P/B ratio of 6.5. The stock trades close to the analyst price target and is considered fairly valued.
Is Procter & Gamble overbought?
No, Procter & Gamble is not overbought. RSI is at 56.3 (neutral zone). The technical indicators show: RSI is at 56.3 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 1.5% above the 20-day average (short-term uptrend). In addition, MACD is positive, but momentum is falling.
When is the next Procter & Gamble earnings report?
Procter & Gamble reports its next earnings on October 22, 2026. The stock currently trades at $148.41. With a P/E ratio of 21.9, the market will be watching closely whether earnings meet expectations.
Is Procter & Gamble shorted?
Yes, Procter & Gamble is shorted with 1.0% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Procter & Gamble stock?
No, insiders are not buying Procter & Gamble shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 17 sales. On a net basis, 8,029,458 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 10,102,880 $ sold. Active sellers include Whaley Susan Street, Schulten Andre, Gama Paul and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Procter & Gamble a good stock?
Based on our total score, Procter & Gamble is rated as a good stock with a total score of 63 out of 100. The stock scores above average on value, quality and momentum. The score is made up of Value: 45/100, Quality: 78/100, Momentum: 67/100. In addition: a dividend of 2.96%; technical signal: Buy. Whether Procter & Gamble is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Procter & Gamble stock?
The outlook for Procter & Gamble based on current data: the average analyst price target is $160.61 (+8.2%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on Oct 22, 2026, which can move the price; the P/E ratio is 21.9 (moderate). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Procter & Gamble stock moving?
Procter & Gamble is stable right now. The technical indicators show: the price is close to the 20-day average; insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Procter & Gamble go?
The average analyst price target for Procter & Gamble is $160.61, which corresponds to a potential gain of 8.2% from the current price of $148.41. The stock has traded between $134.62 and $164.77 over the last 52 weeks. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Procter & Gamble fall?
The stock has traded as low as $134.62 over the last 52 weeks — that is 9.3% below the current price of $148.41. The biggest decline (drawdown) in the same period was 18.3% from high to low. Within a year, the price typically swings about ±19.9% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Procter & Gamble do?
Procter & Gamble, also known as P&G, makes and sells many well-known everyday products. The company earns money by selling these products to consumers around the world. P&G's business is split into five main areas. These include Beauty, with brands like Head & Shoulders and O... The company belongs to the Consumer Defensive sector, more specifically the Household & Personal Products industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Procter & Gamble as an investment.
Did Procter & Gamble raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Procter & Gamble. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Procter & Gamble making money or losing money?
Yes, Procter & Gamble is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 18.4% — which is solid. The operating margin (profit before interest and taxes) is 22.1%. At a P/E ratio of 21.9, you currently pay 21.9 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Procter & Gamble go bankrupt?
The bankruptcy risk of Procter & Gamble is rated as low. Altman Z2 (a model for assessing financial distress) is 4.77 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 7 — which is strong. Debt relative to equity is 140% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Procter & Gamble have a lot of debt?
Procter & Gamble has moderate debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 140%. For the consumer defensive sector, 100-200% counts as a typical level. Consumer staples deliver predictable earnings — which allows higher debt than in cyclical industries. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Procter & Gamble service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 6.2x, and net debt equals 1.0 years of earnings (EBITDA).

Other Stocks in Consumer Defensive

Compare Procter & Gamble with other stocks in the consumer defensive sector. Click a stock to see its technical analysis, insider trading and key figures.

See all 22 stocks in the Consumer Defensive sector